Literature DB >> 34866782

The Clinical Definition of Overbasalization.

Mayer B Davidson1.   

Abstract

Entities:  

Year:  2021        PMID： 34866782      PMCID： PMC8603322          DOI： 10.2337/cd21-0025

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  14 in total

1.  The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Authors:  Louis Monnier; Claude Colette; Gareth J Dunseath; David R Owens
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

2.  Response to Umpierrez et al.

Authors:  Mayer B Davidson
Journal:  Diabetes Obes Metab       Date:  2019-07-10       Impact factor: 6.577

Review 3.  Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin.

Authors:  Kevin Cowart
Journal:  Clin Diabetes       Date:  2020-07

4.  When basal insulin is not enough: response to M Davidson.

Authors:  Guillermo E Umpierrez; Neil Skolnik; Terry Dex; Louise Traylor; Jason Chao; Charles Shaefer
Journal:  Diabetes Obes Metab       Date:  2019-12-05       Impact factor: 6.577

5.  Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin.

Authors:  Katia Bonomo; Alessandro De Salve; Elisa Fiora; Elena Mularoni; Paola Massucco; Paolo Poy; Alice Pomero; Franco Cavalot; Giovanni Anfossi; Mariella Trovati
Journal:  Diabetes Res Clin Pract       Date:  2009-12-01       Impact factor: 5.602

6.  Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.

Authors:  K Cusi; G R Cunningham; J P Comstock
Journal:  Diabetes Care       Date:  1995-06       Impact factor: 19.112

7.  Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials.

Authors:  Helena W Rodbard; Stephen Gough; Wendy Lane; Lars Korsholm; Ditte-Marie Bretler; Yehuda Handelsman
Journal:  Endocr Pract       Date:  2014-04       Impact factor: 3.443

8.  Prevalence of and Characteristics Associated With Overbasalization Among Patients With Type 2 Diabetes Using Basal Insulin: A Cross-Sectional Study.

Authors:  Kevin Cowart; Wendy H Updike; Rashmi Pathak
Journal:  Clin Diabetes       Date:  2021-04

9.  How much is too much? Outcomes in patients using high-dose insulin glargine.

Authors:  T Reid; L Gao; J Gill; A Stuhr; L Traylor; A Vlajnic; A Rhinehart
Journal:  Int J Clin Pract       Date:  2015-11-13       Impact factor: 2.503

10.  BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin.

Authors:  Ariel Zisman; Francienid Morales; John Stewart; Andreas Stuhr; Aleksandra Vlajnic; Rong Zhou
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-13
View more
  2 in total

1.  Clinical Overbasalization Revisited.

Authors:  Mayer B Davidson
Journal:  Clin Diabetes       Date:  2022

2.  A Conversation on an Effective, Straightforward, Quantitative Approach to the Outpatient Use of Insulin.

Authors:  Mayer B Davidson
Journal:  Diabetes Spectr       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.